🟢 Lantern Pharma is trading 5.9% up today in a technical bounce after a sharp regular-session drop

Lantern Pharma is trading at $3.25 (+5.9%) in after-hours trading, appearing to stage a technical bounce following a volatile regular session.

• The stock is rebounding from a sharp 10.1% decline during regular trading on July 14, 2026.
• There are no fresh company-specific headlines, earnings releases, FDA updates, or analyst calls to explain the move.
• The after-hours strength suggests a technical recovery from recent selling pressure rather than a news-driven event.